PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI

Size: px
Start display at page:

Download "PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI"

Transcription

1 JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITARY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR

2 Disclosure Speaker name: Jorge Fernández Noya I have the following potential conflicts of interest to report: X Consulting: GORE Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest

3

4

5 Nitinol Stent Inner layer of eptfe Superb flexibility Low fractures reported in the SFA Heparin-bonded luminal surface for thrombo-resistance Actually up to 25 cm lenght

6 VIABAHN Increased trombogenicity?? Without marks in the edges. The delivery system is not precise Without enought radial force Increased number of Acute ischemia (Occlusion of collaterals)

7 LITERATURE WORLD EXPERIENCE OUR EXPERIENCE

8 ENDOLUMINAL BY-PASS Planning with Duplex-Scan or CT. Usually ipsilateral approach. Angiogram: Looking for healthy vessel proximal and distal ( 1cm) Don t cover genicular arteries Post-dilatation inside the device. Avoid Oversizing ( <20%) Follow-up is critical

9 ENDOLUMINAL BY-PASS Planning with Duplex-Scan or CT.

10 ENDOLUMINAL BY-PASS Avoid Oversizing ( <20%) Effects of Device Sizing: Proximal 91% p< % Effects of Device Sizing: Distal 87% 72% p=0.09 VIPER TRIAL

11 ENDOLUMINAL BY-PASS Angiogram: Looking for proximal and distal ( 1cm) healthy vessel

12 ENDOLUMINAL BY-PASS Don t cover genicular arteries

13 ENDOLUMINAL BY-PASS Post-dilatation inside the device.

14 OUR EXPERIENCE RetrospectIive June 2010-june Patients ( 101 Limbs ) Average Follow up 383 days % male Average age: 72.5 years old.

15 OUR EXPERIENCE 0,7 0,6 0,5 0,4 0,3 0,2 0,1 0

16 OUR EXPERIENCE DISTAL PTA/STENT DISTAL SURGERY PROXIMAL BARE STENT PROXIMAL FEM- OPEN SURGERY NO ASSOCIATE PROCEDURE. ILIAC OPEN SURGERY ILIAC PTA/STENT 57.1% ASSOCIATE PROCEDURE

17 OUR EXPERIENCE CATEGORY 4: ISCHEMIC REST PAIN 28.5% CATEGORY 5: MINOR TISSUE LOSS 63.3% CATEGORY 6: MAJOR TISSUE LOSS 8.2%

18 OUR EXPERIENCE LESIONS CHARACTERISTICS Occlusions 78.6% Stenosis 21.4% Calcification Mild 41.8% Moderate 37.8% Severe 20.4% 58.2% Length < 10 cm 15.3% cm 32.7% >20 cm 52% Run off 0 5.1% 1 52% 84.7% 57.1% % %

19 OUR EXPERIENCE GLOBAL RESULTS Primary Patency Secondary Patency Limb Salvage Time ( Days) Time ( Days) Time ( Days) PRIMARY PATENCY SECONDARY PATENCY LIMB SALVAGE 1 YEAR 78.8 % 82.2% 88% 2 YEARS 71,7 % 74,8 % 82,1%

20 OUR EXPERIENCE DIABETES Primary Patency DIABETICS----- NON-DIABETICS---- Limb Salvage Time ( Days) PRIMARY PATENCY DIABETICS NON- DIABETICS 1 year 78.3% 79.5% 2 years 70.7% 74.2% Time ( Days) LIMB SALVAGE DIABETICS NON DIABETICS 1 year 89.8% 84.2% 2 years 80.4% 84.2%

21 OUR EXPERIENCE RUTHERFORD CATEGORY --- Rutherford 4 Primary Patency --- Rutherford Rutherford 6 Limb Salvage Time ( Days) PRIMARY PATENCY year 75.3% 83.2% 50% 2 years 75.3% 71.3% Time ( Days) LIMB SALVAGE year 94.7% 91.6% 37.5% 2 years 94.7% 85% -----

22 OUR EXPERIENCE LENGTH < 10 cm cm---- PRIMARY PATENCY <10 cm cm >20 cm 1 year 86.2% 89.4% 69.6% Primary Patency >20 cm 2 years 76.6% 89.4% 58% Time ( Days) LENGTH>20 Cm Primary patency 1 STENT 79% 2 STENT 64.7% 3 STENT 66.7%

23 OUR EXPERIENCE LENGTH < 10 cm--- Limb Salvage cm---- >20 cm LIMB SALVAGE <10 cm cm >20 cm 1 year 86.7% 93.3% 85.4% Time ( Days) 2 years 69.3% 88.1% 85.4%

24 CONCLUSIONS Long SFA lesions and CLI are challenging cases Endoluminal by-pass technique offers good results 250 mm graft to avoid the overlapping (ENDO-BY-PASS) Correct sizing is key / Avoid Oversizing Surveillance is critical The edge-focal stenosis is easier to treat

25 THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR

Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial

Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have

More information

RESULTS OF VIABAHN IN AORTO ILIAC OCCLUSION

RESULTS OF VIABAHN IN AORTO ILIAC OCCLUSION RESULTS OF VIABAHN IN AORTO ILIAC OCCLUSION JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA ALTERNATIVAS ENDOVASCULAR TERAPÉUTICAS TREATMENT

More information

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,

More information

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for

More information

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

2-YEAR DATA SUPERA POPLITEAL REAL WORLD 2-YEAR DATA SUPERA POPLITEAL REAL WORLD Enrique M. San Norberto. Angiology and Vascular Surgery. Valladolid University Hospital. Valladolid. Spain. Disclosure Speaker name: ENRIQUE M. SAN NORBERTO I have

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker

More information

Endovascular treatment of severe TASC C and D external iliac artery occlusive disease. SAINT-LEBES Bertrand Toulouse FRANCE

Endovascular treatment of severe TASC C and D external iliac artery occlusive disease. SAINT-LEBES Bertrand Toulouse FRANCE Endovascular treatment of severe TASC C and D external iliac artery occlusive disease SAINT-LEBES Bertrand Toulouse FRANCE Disclosure Speaker name: SAINT-LEBES I have the following potential conflicts

More information

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have

More information

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Disclosure I have nothing to disclose Randomized Controlled Studies In SFA Technology: What s The Best Tool For

More information

Balloon Expandable Covered Stents. Suddenly a Crowded Space

Balloon Expandable Covered Stents. Suddenly a Crowded Space Novel Balloon Expandable Covered Stents for Aorto-iliac Occlusive Disease: New Trial Data makes for an Interesting Balloon Expandable Covered Stents Comparison in Aorto-iliac Occlusive Disease: Andrew

More information

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results Hiroyoshi Yokoi, MD, Fukuoka Sannou Hospital Fukuoka, Japan On behalf

More information

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA Disclosures No financial disclosures. Cameron M. Akbari, MD, MBA, FACS Site Director, Vascular Surgery Medstar

More information

Mid-term outcome of CERAB for aorto-iliac occlusive disease. Michel Reijnen Rijnstate Arnhem The Netherlands

Mid-term outcome of CERAB for aorto-iliac occlusive disease. Michel Reijnen Rijnstate Arnhem The Netherlands Mid-term outcome of CERAB for aorto-iliac occlusive disease Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report G. Biro, M. Bosiers on behalf of ZILVERPASS Study Group Disclosure Speaker

More information

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard?

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard? Disclosures Boston Scientific, Medical Advisory Board Endologix Corp., Consultant and trainer, AFX Aorto-Iliac Disease: Bare Metal, Covered or Stent Grafts How I Decide John S. Lane III MD, FACS Professor

More information

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division

More information

I am no good at debates!

I am no good at debates! Disclosure Statement of Financial Interest Imaging Strategy for Claudication: Ultrasound Alone is Not Adequate to Select Patients for Endovascular Intervention Within the past 12 months, I or my spouse/partner

More information

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology The Crack and Pave technique for highly resistant calcified lesions Manuela Matschuck MD University Hospital Leipzig Department Angiology Disclosure Speaker name: Dr. med. Manuela Matschuck I have the

More information

Accurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery

Accurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery Accurate Vessel Sizing Drives Clinical Results IVUS In the Periphery Discussion Iida O, et. al. Study Efficacy of Intravascular Ultrasound in Femoropopliteal Stenting for Peripheral Artery Disease With

More information

Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results.

Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Wronski J. 1), 2) 3), Wilczynski M 1), Gembal P 1), Milik K 1), Dec St 1), Grybos

More information

Pedal Bypass With Deep Venous Arterialization:

Pedal Bypass With Deep Venous Arterialization: Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj

More information

The LIMBO trial: a RCT investigating adventitial dexamethasone infusion to prevent restenosis in BTK arteries utilizing a novel angiographic endpoint

The LIMBO trial: a RCT investigating adventitial dexamethasone infusion to prevent restenosis in BTK arteries utilizing a novel angiographic endpoint The LIMBO trial: a RCT investigating adventitial dexamethasone infusion to prevent restenosis in BTK arteries utilizing a novel angiographic endpoint Dr. Ulrich Beschorner Universitäts Herzzentrum Freiburg

More information

The latest evidences from the DES trials in peripheral arterial disease

The latest evidences from the DES trials in peripheral arterial disease The latest evidences from the DES trials in peripheral arterial disease Michael D. Dake, MD Thelma and Henry Doelger Professor Stanford University School of Medicine Disclosure Speaker name: Michael D.

More information

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI 1 Disclosures I have no financial disclosures related to this talk Objectives 1. Discuss indications for intervention

More information

Update from Korea on the Lutonix SFA registry 12 month data

Update from Korea on the Lutonix SFA registry 12 month data Update from Korea on the Lutonix SFA registry 12 month data Prospective, Multicenter, Post-Market Registy Assessing the Clinical Use and Safety of the Lutonix Drug Coated Balloon in Femoropopliteal Arteries

More information

How do I use mechanical debulking for the treatment of arterial occlusions

How do I use mechanical debulking for the treatment of arterial occlusions How do I use mechanical debulking for the treatment of arterial occlusions Sven Bräunlich, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Sven Bräunlich

More information

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have

More information

Chimney technique combined with aortoiliac stenting for the treatment. disease. of juxtarenal aortoiliac occlusive

Chimney technique combined with aortoiliac stenting for the treatment. disease. of juxtarenal aortoiliac occlusive Chimney technique combined with aortoiliac stenting for the treatment of juxtarenal aortoiliac occlusive disease Suwanruangsri Veera,MD Kaviros Pruesttipong,MD Department of Surgery, Maharat Nakhon Ratchasima

More information

Anatomical challenges in EVAR

Anatomical challenges in EVAR Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting

More information

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization A Sonetto, M Abualhin, M Gargiulo, GL Faggioli, A Stella Disclosure Speaker

More information

Study of a Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery

Study of a Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery Study of a Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery First Look at the 24-Month Results of the BOLSTER Trial John R. Laird, MD, on behalf of the Investigators Adventist

More information

Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert

Surgical Bypass or. Zilver PTX. 12 months preliminary data. LINC 2016, Leipzig. Marc Bosiers, MD. Marc Bosiers Koen Deloose Joren Callaert LINC 2016, Leipzig Surgical Bypass or A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist Wouter Van den Eynde OLV Hospital,

More information

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION ARMANDO MANSILHA MD, PhD, FEBVS UNIVERSITY HOSPITAL - PORTO Disclosure of Interest Speaker name: ARMANDO MANSILHA I have the following potential conflicts

More information

DIFFICULT ACCESS REMAINS A CONTRAINDICATION FOR EVAR APOSTOLOS K. TASSIOPOULOS, MD, FACS PROFESSOR AND CHIEF DIVISION OF VASCULAR SURGERY

DIFFICULT ACCESS REMAINS A CONTRAINDICATION FOR EVAR APOSTOLOS K. TASSIOPOULOS, MD, FACS PROFESSOR AND CHIEF DIVISION OF VASCULAR SURGERY DIFFICULT ACCESS REMAINS A CONTRAINDICATION FOR EVAR APOSTOLOS K. TASSIOPOULOS, MD, FACS PROFESSOR AND CHIEF DIVISION OF VASCULAR SURGERY Disclosures Speaker Bureau: - Medtronic - Cook Medical - Bolton

More information

Extreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm. Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio

Extreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm. Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio Extreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio Extreme SFA Lesions: DETOUR I 12-Month Results in Lesions >30cm

More information

Treatment Strategies for Long Lesions of greater than 20 cm

Treatment Strategies for Long Lesions of greater than 20 cm Treatment Strategies for Long Lesions of greater than 20 cm Donald L. Jacobs, MD C. Rollins Hanlon Professor and Chair Chair of the Department of Surgery Saint Louis University Disclosure Speaker name:

More information

Robert F. Cuff, MD FACS SHMG Vascular Surgery

Robert F. Cuff, MD FACS SHMG Vascular Surgery Robert F. Cuff, MD FACS SHMG Vascular Surgery Objectives To become familiar with the commercially available fenestrated EVAR graft Discuss techniques to increase success Review available data to determine

More information

The Fate of Unexpected Events Occurring in Standard EVAR

The Fate of Unexpected Events Occurring in Standard EVAR The Fate of Unexpected Events Occurring in Standard EVAR Andrea Stella Alma Mater Studiorum - University of Bologna Disclosure Speaker name: Prof. Andrea Stella I have the following potential conflicts

More information

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly Stents for The Common Femoral Artery: The Good, The Bad and The Ugly Salman Arain, MD, FACC Assistant Professor of Medicine - Cardiology University of Texas Health Sciences Center Houston Texas, USA Disclosure

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France www.incathlab.com Disclosure Speaker name: Max Amor, MD.... I have the following

More information

GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands

GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts

More information

Disclosures: Stent-grafts for Long-Segment SFA Disease: Better than the Alternatives? SFA Treatment Overview: Longer Lesions 4/18/2013

Disclosures: Stent-grafts for Long-Segment SFA Disease: Better than the Alternatives? SFA Treatment Overview: Longer Lesions 4/18/2013 Stent-grafts for Long-Segment SFA Disease: Better than the Alternatives? Richard Saxon MD Director of Research San Diego Cardiac and Vascular Institute San Diego Imaging Medical Group San Diego, CA Disclosures:

More information

Variation of stent placement for distal abdominal aorta Lesion

Variation of stent placement for distal abdominal aorta Lesion Variation of stent placement for distal abdominal aorta Lesion Tatsuki Doijiri M.D Department of Cardiology Yamato-Seiwa Hospital Kanagawa Japan Disclosure Speaker name: Tatsuki Doijiri... I have the following

More information

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea Catheter-Directed Thrombolysis for Acute Limb Ischemia Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea Disclosure Speaker name: Hwan Jun Jae... I have the following potential conflicts

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture

Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture Miyazaki Medical Association Hospital Cardiovascular Center

More information

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial) Final results of the feasibility study for the drug-coated Chocolate Touch PTA balloon of of femoropopliteal Femoropopliteal lesions lesions: (The ENDURE Trial) Final Results of the Feasibility Study for

More information

Hypogastric Preservation Using Retrograde Endovascular Bypass

Hypogastric Preservation Using Retrograde Endovascular Bypass Hypogastric Preservation Using Retrograde Endovascular Bypass Mathew Wooster MD, Adam Tanious MD, Brad Johnson MD, Murray Shames MD, Paul Armstrong MD, Martin Back MD Florida Vascular Society 30 th Annual

More information

Long-term Zilver PTX Data from Japan: 5-year Results in the Real World

Long-term Zilver PTX Data from Japan: 5-year Results in the Real World Long-term Data from Japan: 5-year Results in the Real World Hiroyoshi Yokoi, MD Department of Cardiovascular Medicine Fukuoka Sanno Hospital Fukuoka, Japan On behalf of the Investigators Disclosure Speaker

More information

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany ISR-treatment The Leipzig experience with purely mechanical debulking Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Sven Bräunlich I have the following

More information

Present & future of below the knee stenting

Present & future of below the knee stenting Session 5 Below the knee arteries & limb salvage Present & future of below the knee stenting M. Bosiers K. Deloose P. Peeters 1 PRESENT Clinical perspective whom to treat CRITICAL LIMB ISCHEMIA (CLI) 0

More information

Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft

Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical

More information

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

Expanding to every demand: The GORE VIABAHN VBX Stent Graft Expanding to every demand: The GORE VIABAHN VBX Stent Graft GORE, VIABAHN, and designs are trademarks of W. L. Gore & Associates. 2017 W. L. Gore & Associates, Inc. Program Faculty Martin Austermann, MD

More information

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide 2-Year Results Of The Tack Optimized Balloon Angioplasty (TOBA) Trial For Fem- Pop Lesions Demonstrates Safety and Efficacy Of The Tack Endovascular System In Repairing Focal Post-PTA Dissections Christian

More information

ILLUMENATE FIH Direct DCB Cohort 12-Month Results

ILLUMENATE FIH Direct DCB Cohort 12-Month Results ILLUMENATE FIH Direct DCB Cohort 12-Month Results Stephan Duda Berlin Study Investigators: H. Schröder (PI), B. Lux, F. Rücker, M. Martorana, D. Meyer, H. Hartmann, S. Duda Disclosure Speaker name: S.

More information

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis- Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis- Masahiko Fujihara Kishiwada Tokushukai Hospital, Osaka, Japan Disclosure

More information

CLI Treatment Using Long and Scoring Balloons

CLI Treatment Using Long and Scoring Balloons CLI Treatment Using Long and Scoring Balloons Robert Beasley, MD Director of Vascular and Interven3onal Radiology Mount Sinai Medical Center Miami Beach, FL Disclosures Consultant/Advisory Board: Abbott

More information

Long Lesions: Primary stenting or DCB first? John Laird MD Adventist Heart and Vascular Institute, St. Helena, CA

Long Lesions: Primary stenting or DCB first? John Laird MD Adventist Heart and Vascular Institute, St. Helena, CA Long Lesions: Primary stenting or DCB first? John Laird MD Adventist Heart and Vascular Institute, St. Helena, CA Disclosures John R. Laird Within the past 12 months, I or my spouse/partner have had a

More information

SFA In-stent Restenosis

SFA In-stent Restenosis Disclosure In-Stent Restenosis: Endo-Salvage Works for Most Patients Peter A. Schneider, MD Hawaii Permanente Medical Group and Kaiser Foundation Hospital Honolulu, Hawaii Peter A. Schneider Potential

More information

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery PRISM Trial Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery George L. Adams, MD, MHS, FACC, FSCAI Clinical Associate Professor

More information

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA BATTLE RCT investigators: Y. Gouëffic, A. Sauguet, P. Desgranges, P. Feugier, E. Rosset, E. Ducasse,

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort a.o. Univ. Prof. Dr. Marianne Brodmann Medical University of Graz Graz,

More information

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE

More information

Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster

Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Disclosure Speaker name:...michel Bosiers... I have the following potential conflicts of interest to report: Consulting Employment

More information

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Marianne Brodmann, MD Head of the Clinical Division of Angiology Department of Internal Medicine Medical University

More information

The essentials for BTK procedures: wires, balloons, what else

The essentials for BTK procedures: wires, balloons, what else A comprehensive approach to diabetic patient Tx The essentials for BTK procedures: wires, balloons, what else Dai-Do Do Clinical and Interventional Angiology Cardiovascular Department Disclosure Speaker

More information

Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff

Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff P. Kuryanov, A. Lipin, A. Antropov, K. Atmadzas, A. Atmadzas, Y. Eminov, A. Borisov, R. Sobolev, A.Orlov Limb

More information

Introduction History Preceded by Arterial Doppler and ABI Indications

Introduction History Preceded by Arterial Doppler and ABI Indications Elise Brady, RVT, RDMS Introduction History Preceded by Arterial Doppler and ABI Indications 1) Abnormal ABI (within 2weeks of duplex) 2) Abnormal Doppler waveforms 3) Claudication 4) History of PVD 5)

More information

CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES

CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES A SERIES OF THREE CASE REPORTS Joel Sousa Department of Department of Angiology and Vascular Surgery Hospital S. João, Porto,

More information

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following

More information

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial) Final results of the feasibility study for the drug-coated Chocolate Touch PTA balloon of of femoropopliteal Femoropopliteal lesions lesions: (The ENDURE Trial) Final Results of the Feasibility Study for

More information

Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making

Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making Critical limb ischemia due to an occlusion of an aorto-biiliac prothesis step by step case presentation and decision making Dr. Özgün Sensebat Vascular and general surgeon Vascular Private Clinic Dorsten

More information

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts Dr Steven Kum MBBS MMed FRCS FAMS Vascular & Endovascular Surgeon Vascular Centre Department of Surgery Changi

More information

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁 Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁 Contents DES in SFA DES in BTK DEB in SFA DEB in BTK Current status of covered stent

More information

How effective is preservation when viewed through a clinical and economic lens?

How effective is preservation when viewed through a clinical and economic lens? How effective is preservation when viewed through a clinical and economic lens? Nilo J Mosquera, MD. Head of Department Angiology and Vascular Surgery Department. Complexo Hospitalario Universitario de

More information

Popliteal Artery Aneurysms: Diagnosis and Repair Options

Popliteal Artery Aneurysms: Diagnosis and Repair Options Deepak N. Deshmukh DO April 27, 2018 Popliteal Artery Aneurysms: Diagnosis and Repair Options No Disclosures Popliteal Artery Aneurysms (PAAs) Male Predominanace Most common peripheral Aneurysm (70%) 30-50%

More information

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Surgical Options for revascularisation P E T E R S U B R A M A N I A M Surgical Options for revascularisation P E T E R S U B R A M A N I A M The goal Treat pain Heal ulcer Preserve limb Preserve life The options Conservative Endovascular Surgical bypass Primary amputation

More information

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)

More information

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany Intravascular Stenting and Angiographic Results: Randomized Comparison of STenting, Stenting after Paclitaxel-eluting balloon and ATHerectomy in patients with symptomatic Peripheral Artery Disease - Results

More information

Cutting/scoring balloon Cryoplasty Drug-eluting balloon Brachytherapy Debulking Restent (BMS or DES) John R. Laird, MD

Cutting/scoring balloon Cryoplasty Drug-eluting balloon Brachytherapy Debulking Restent (BMS or DES) John R. Laird, MD Current Treatment of Femoropopliteal Instent Restenosis Professor of Medicine Medical Director of the Vascular Center UC Davis Medical Center SFA In-stent Restenosis Common: 18%- 40% at 12 months in recent

More information

Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips.

Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips. Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips. Dr. Bruno Freitas, Prof., MD Department of Interventional

More information

Clinical benefits on DES Patient s perspectives

Clinical benefits on DES Patient s perspectives Clinical benefits on DES Patient s perspectives Dr. Skyi Pang Vascular Surgeon Department of Surgery Pamela Youde Nethersole Eastern Hospital Hong Kong Disclosure Speaker name: Skyi Pang... I have the

More information

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery

More information

Talent Abdominal Stent Graft

Talent Abdominal Stent Graft Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck

More information

COMBINED TECHNIQUE CHIMNEY + FENESTRATED ENDOGRAFT FOR COMPLEX ANEURYSMS ERIC DUCASSE - MD PHD FEVBS CHU BORDEAUX

COMBINED TECHNIQUE CHIMNEY + FENESTRATED ENDOGRAFT FOR COMPLEX ANEURYSMS ERIC DUCASSE - MD PHD FEVBS CHU BORDEAUX COMBINED TECHNIQUE CHIMNEY + FENESTRATED ENDOGRAFT FOR COMPLEX ANEURYSMS ERIC DUCASSE - MD PHD FEVBS CHU BORDEAUX DISCLOSURE SPEAKER NAME: PR. E. DUCASSE I HAVE THE FOLLOWING POTENTIAL CONFLICTS OF INTEREST

More information

Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue

Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue Robert M. Bersin, M.D. Director, Endovascular Services Seattle Cardiology and the Cardiovascular

More information

FLEXIBLE, BALOON EXPANDABLE

FLEXIBLE, BALOON EXPANDABLE EARLY RESULTS OF A CLINICAL TRIAL OF FLEXIBLE, BALOON EXPANDABLE COVERED STENT GRAFT IN ILIAC OCCLUSIVE DISEASE Chris LeCroy Coastal Vascular and Interventional Pensacola, Florida Clinical Trial WL GORE

More information

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan COI disclosure Disclosure Speaker name: Taku Kato... I have the

More information

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions Michinao Tan, MD Tokeidai Memorial Hospital Cardiovascular

More information

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of

More information

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC 2017 January 25 th 2017 Disclosure

More information

Durable outcomes. Proven performance.

Durable outcomes. Proven performance. Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable

More information

Pulsar stent technology

Pulsar stent technology Pulsar stent technology Michael K. W. Lichtenberg Vascular Center Arnsberg Disclosures Speaker name: Michael Lichtenberg... I have the following potential conflicts of interest to report: X Consulting

More information

Evidence-Based Optimal Treatment for SFA Disease

Evidence-Based Optimal Treatment for SFA Disease Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular

More information

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine

More information

Atherectomy is Still Live and Effective. John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System

Atherectomy is Still Live and Effective. John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System Atherectomy is Still Live and Effective John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System Why is Atherectomy Still Alive? Improved devices Better data

More information